Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of Xuan Li being referenced
Safety and Efficacy of the Passeo-18 Lux Drug-Coated Balloon Catheter in Atherosclerotic Femoropopliteal Lesions: The Multicenter BIOLUX P-IV China Study
2023
Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xuan Li | 363 | 348 | 501 | 444 | 88 | 1.2k | |
| Katsutoshi Shoda | 399 | 349 | 726 | 652 | 116 | 1.5k | |
| Zhiqiang Ma | 400 | 434 | 362 | 204 | 72 | 1.2k | |
| Qun Zhao | 414 | 262 | 469 | 338 | 130 | 1.2k | |
| Shuqiang Yuan | 582 | 261 | 408 | 346 | 68 | 1.1k | |
| Maria Rosaria Giovagnoli | 345 | 324 | 408 | 469 | 92 | 1.3k | |
| Bo Wang | 333 | 284 | 820 | 480 | 55 | 1.4k | |
| Kyungeun Kim | 302 | 241 | 491 | 212 | 84 | 1.2k | |
| Xin Liu | 455 | 167 | 382 | 262 | 54 | 1.0k | |
| Annalisa Altimari | 251 | 264 | 372 | 249 | 72 | 1.1k | |
| Francesca Galuppini | 200 | 295 | 492 | 378 | 71 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...